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THE expectation of life for patients with cerebral astrocytomata of high-
grade malignancy is very poor with orthodox treatment. Fifty to sixty per
cent of patients die within 3 months and 90 per cent within 18 months. whether
treatment consists of surgery alone or surgery combined with radiotherapy
(Penman, 1961, unpublished data). Preliminary observations describing an
apparent increase in radiosensitivity of these tumours, when irradiated under
mild whole-body hypothermia, have been reported by us previously (Bloch et al.,
1961). It was postulated that reduction in oxygen consumption and increase in
dissolved plasma oxygen during hypothermia might lead to increased oxygen
availability in the tissues resulting in an improved tumour response.
Our original intention was to conduct a controlled clinical trial to compare
the effects ofirradiation to the brain at normal and at reduced body temperatures.
This was to be carried out in two groups of otherwise similar patients, having
proven grades III or IV astrocytomata (classification of Kernohan et al., 1949),
for which cerebral decompression, with extensive removal oftumour, had recently
been carried out. The next-of-kin of each patient was interviewed, the prognosis
for the patient was discussed, and the possible dangers of prolonged hypothermia
were clearly explained before permission to treat the patient was accepted.
During hypothermia a marked increase in the response of cerebral tissues to
irradiation was observed so that an incident dose of 150 r daily to each side of the
skull, covering the entire cerebral hemisphere, was tolerated for only 2 or 3
consecutive days (250 kv; 15 mA; H.V.L., 3*4 mm. Cu; dose rate 32 r per min.;
field size 10 x 15 cm.). There was also evidence of a differential sensitivity
between tumour and normal cerebral tissue, which we thought to favour treatment
of the tumour. Owing to the limited dose of irradiation tolerated in cooled
patients the controlled clinical trial was abandoned and our efforts were then
directed to increasing the total dose of irradiation under hypothermia by giving
repeated short courses of treatment at intervals of 7-10 days. The technique of
inducing and maintaining hypothermia was described in our previous communica-
tion (Bloch et al., 1961).
OBSERVATIONS
(a) Irradiation during a single course of hypothermia
Irradiated patients developed signs of an acute cerebral reaction which varied
from slight drowsiness and confusion, or mild hemiparesis, to deep coma and
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flaccid tetraplegia, appearing within 2 to 3 days of commencing irradiation, when
the total midline dose to the brain was between 300 to 450 r. These patients
were treated with urea (50 g. in 180 ml. water by gastric tube) and the subsequent
improvement, usually within one hour, suggested that deterioration had been
due to cerebral oedema. In 2 patients even smaller doses ofirradiation produced
clinical changes: one case received 50 r daily incident to each hemisphere, and
the other an initial dose of 50 r increasing by 25 r daily. Both these patients
showed evidence of mild generalised depression of the central nervous system,
after receiving a total dose of 200 r and 225 r respectively to each side of the
skull. Subsequently, some patients were found to tolerate as much as 200 r
daily to each side of the skull, but it still was not possible to irradiate them for
more than 3 consecutive days without producing a cerebral reaction.
(b) Irradiation during multiple courses ofhypothermia
During the first cooling episode, 200 r to each hemisphere was given on each
of 2 consecutive days. If this was well tolerated, 3 days treatment was given
during the second cooling but in some patients this resulted in drowsiness. In
this way it was possible to deliver a total incident dose to each hemisphere cor-
responding to a total midline dose of 3000-4000 r, during a course of 5-7 episodes
of hypothermia. The greatest number of times any one patient was cooled was
nine. On the few occasions when irradiation was given on 4 instead of 3 consecu-
tive days, gross deterioration occurred leading to stupor or coma and on one
occasion contributing to a fatal result. Thereafter irradiation was limited to
not more than 3 days during any single episode of hypothermia.
In 4 cases, a control period of hypothermia without irradiation, lasting 4,
6, 6 and 4 days respectively, was undertaken, the intention being to administer
the combined treatment of irradiation and hypothermia after an interval of 2
to 3 weeks, ifhypothermia alone was well tolerated. In 2 further cases irradiation
to the brain was postponed until the 4th and 8th days respectively of continuous
hypothermia. Noneofthese 6 patients showed anysigns ofneurological deteriora-
tion and, with one exception, remained well and alert throughout the period of
control hypothermia, suggesting that the cerebral reaction to irradiation at a
body temperature of 30-33° C. could not be attributed to hypothermia alone.
The exception, a woman of 52 years, developed signs of acute circulatory failure
on the 4th day of hypothermia and died some 14 hours later. Autopsy revealed
evidence of acute pancreatitis with extensive fat necrosis, involving particularly
the tail ofthe pancreas. At first the patient denied the presence ofpain or other
symptoms and clinical evidence of an intra-abdominal catastrophe could not be
found. To avoid masking possible symptoms, pethidine, used to assist in the
control ofhypothermia, was discontinued. It was only a few hours before death
that abdominal pain and muscle guarding appeared.
RESULTS OF TREATMENT
Thirty patients have been studied. Twenty-eight were treated by irradiation
to the brain under hypothermia following surgical decompression; one patient
was treated without preliminary decompression, and one (see 2 below) by decom-
pression and hypothermia alone. Ten ofthese 30 patients died during treatment:
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1. The first 3 patients died as a result of the combined effects of irradiation,
prolonged hypothermia (18 and 21 days for 2 patients) and pulmonary infection.
It was not immediately appreciated that the dose ofirradiation, small by conven-
tional standards at normal temperature, could produce such marked effects.
2. One patient received a preliminary period of control hypothermia without
irradiation to the brain. This was well tolerated, but whilst waiting to undergo
a course of hypothermia with irradiation there were signs of further tumour
growth and it was considered unlikely that he would benefit from treatment.
3. Of the remaining 6 patients, 3 died from pulmonary infection, one from
multiple causes (irradiation to the brain under hypothermia, acute pancreatitis,
secondary infection and rewarming complications), one from acute phlegmonous
gastritis and one from acute pancreatitis.
Patient mortality during treatment was high (33 Even ifthe first 4 cases
are excluded, the mortality is still 23% (6 of 26 cases). The mortality for the
total episodes of hypothermia was 10 out of 80 (12.5%) or, excluding the first
4 cases, 6 out of 76 (7-9%).
Twenty patients survived treatment and the details of these are given in
Table I. Case 6 was given three courses of treatment, separated by intervals of
7 and 3 months. In case 21 and case 27, treatment under hypothermia was
abandoned after a total incident dose of 300 r and 1400 r respectively; in the
first this was due to technical difficulties unrelated to the patient, and in the
second to acute epididymo-orchitis which took several weeks to resolve. Both
TABLE L.-Dose and Survival in Thirty Patients Treated by Irradiation
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patients subsequently received supplementary irradiation at normal body tempera-
ture.
In Penman's (1961, unpublished) series of 188 patients (grade III and IN"
astrocytoma) treated at normal body temperature by surgery and post-operative
radiotherapy, approximately 50% died within 3 months, 62% within 6 months,
80% within one year and 88% within 18 months. Five (25%) of our patients
who survived treatment died within 3 months, 13 (65%) within 6 months and
18 (90%0) within one year.
We should like to refer to a number of other observations made during this
investigation.
(1) Special 8ense8. Five patients who received multiple courses of irradiation
under hypothermia developed mild transient deafness and one ofthese complained
also of transient loss of sense of smell and taste. In one patient deafness was
noticed after a mid-line dose of 1430 r had been given during three courses of
hypothermia, over a total period of 16 days. In 2 patients deafness was noticed
after doses of 2000 r and 2800 r had been given in 6 and 5 episodes ofhypothermia,
respectively. It is probable that in all 3 cases the deafness could have been
detected at an earlier stage had this been especially looked for.
(2) Cerebro8pinal fluid protein. Cerebrospinal fluid protein concentration
increased in a number of patients during irradiation under hypothermia, and
for the following reasons this was considered the result of cerebral irradiation
rather than hypothermia:
(i). In a patient cooled for 6 days without irradiation to the brain, C.S.F.
protein concentration was 70 mg. per 100 ml. during the first 4 days ofhypothermia
and 85 mg. per 100 ml. on the last. This rise is not significant.
(ii). In 4 patients the period of hypothermia was extended after irradiation
to the brain had been completed. The C.S.F. protein concentration increased
during irradiation, reached a maximum value 1 or 2 days after irradiation was
completed, and then fell rapidly despite continued hypothermia. In 1 of these
patients the protein concentration increased from 160 to 300 mg./l1Oml. following
irradiation but during the next 2 days fell to 275 and 250 mg./100 ml. respectively.
In a second patient the protein increased from 110 to 325 mg./100 ml. and fell
to 225 and 120 mg./100 ml. respectively during the next 2 days. In the 3rd
and 4th patients the rise in protein was only moderate, from 50 to 100 mg./100 ml.
and from 50 to 140 mg./100 ml.
Increase in C.S.F. protein concentration was observed in several other cooled
patients during or following irradiation to the brain. In these, however, hypo-
thermia had been terminated within 24 hours of completion of irradiation, and
it could not be deduced whether the subsequent fall in protein resulted from
cessation of hypothermia or of irradiation. It seems likely, however, that the
rise and fall in C.S.F. protein during hypothermia was related to irradiation to
the brain. Increase in C.S.F. protein could not be correlated with dose ofirradia-
tion, or with the severity of the clinical response to treatment.
In some patients a second rise in C.S.F. protein occurred during rewarming,
and this was of interest because of other central nervous system manifestations,
namely, rise in C.S.F. pressure, drowsiness and paresis appearing at that time
(Bloch, 1965). In the patient described above, in whom C.S.F. protein did not
change significantly during 6 days of hypothermia, rewarming was associated
with a rise in protein level from 85 to 130 mg./100 ml. within 48 hours, and to
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180 mg./100 ml. 3 days later. The patient became drowsy during rewarming
but had improved at the time the C.S.F. protein had increased to 180 mg./100 ml.
In another patient, cooled for 8 days and irradiated on the first 4 ofthese, C.S.F.
protein rose from 30 to 140 mg./100 ml., but fell to 90 mg./100 ml. by the final
day of hypothermia. During rewarming it rose again, to 120 mg./100 ml.
In view of the risks attached to lumbar puncture in patients having supra-
tentorial tumours, C.S.F. examination is not usually made during irradiation of
cerebral gliomata, and we have been unable to find information concerning
changes in C.S.F. protein during irradiation ofthe brain at normal body tempera-
ture. Since in all our patients a large cerebral decompression had been the initial
treatment, we considered lumbar puncture to be safe, particularly during hypo-
thermia, and this proved to be the case.
(3) Peripheral Blood Changes. During the first 24-48 hours of hypothermia
there is a rise in haematocrit and haemoglobin values and in red cell count.
This results from loss of fluid from the intravascular to the interstitial and prob-
ably to the intracellular compartments. During prolonged hypothermia these
values return towards normal as a result of a reduction in the number of circu-
lating red cells. During rewarming the reverse occurs; i.e. increase in plasma
volume precedes rise in circulating red cells, resulting in a temporary fall in
haematocrit, haemoglobin and red cell count (Bloch, 1965).
The response of the white blood cells to mild prolonged hypothermia varies.
Whereas the number of circulating neutrophils may rise, fall or remain relatively
unaltered, lymphocytes and monocytes generally show a profound fall, and baso-
phils and eosinophils may disappear completely, within 24-48 hours. These
changes persist throughout the period of hypothermia and may take 2-4 days to
return to normal following rewarming (Bloch, 1963).
The platelet count may fall to less than 100,000/c.mm. by the end of 7 to 10
days of hypothermia (Bloch et al., 1961).
(4) Pancreatitis. Acute fat necrosis of the pancreas occurred twice during
80 episodes of hypothermia. In one patient (hypothermia without irradiation)
this was the immediate cause ofdeath and in the other (hypothermia with irradia-
tion) a contributory cause.
Acute pancreatitisduringhypothermiahas beendescribedbyseveralobservers.
The reported incidence of this complication varies and, particularly in accidental
hypothermia, may be related to the presence of such complicating factors as
coma, respiratory infection, exposure, drugs and injury. Sano and Smith (1940)
reported a 10 per cent incidence of pancreatitis as a chance finding at autopsy of
patients in whom hypothermia alone was used as a treatment for disseminated
carcinoma, and who subsequently died, often after an interval of many months.
These authors describe lesions that range from gross foci of fat necrosis and
haemorrhage to similar lesions demonstrable only microscopically. It is possible
that the actual incidence of microscopic changes during hypothermia was greater
than 10%. Duguid, Simpson and Stowers (1961) described 23 patients suffering
from accidental hypothermia and found post-mortem evidence of pancreatitis
in 5 of 13 of these patients: acute haemorrhage necrosis was present in 2, and
focal pancreatic and fat necrosis in 3. Fisher, Fedor and Fisher (1957), in their
observations on experimental hypothermia in dogs, found evidence of non-
haemorrhagic pancreatitis with associated necrosis of peripancreatic adipose
tissue in 10% of their animals in which this organ was examined.
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(5) Acute Epididymo-orchitis. This occurred in one patient following 3
episodes of hypothermia and irradiation. Urine culture was sterile. Culture
and guinea-pig inoculation tests for tubercle bacilli were negative. Although
testicular lesions have not been described in clinical reports concerning tissue
changes due to hypothermia, Delauney and Lebrun (1954) referred to severe
necrotic and pyknotic changes in the lymphoid tissue and testicles of rats cooled
to 150 C. for 7 hours. Jones (1962), however, found no evidence of testicular
damage in rats cooled for periods up to 27 hours at 20-22O C. Thus, although
acute epididymo-orchitis in our case may have resulted from hypothermia, it
may have been a complication of catheterisation, despite the lack of evidence of
urinary infection.
DISCUSSION
Under conditions of mild hypothermia (30-33°C., rectal temperature) there
is an increase in the sensitivity of cerebral tissues to irradiation. There is some
evidence that the response of the tumour may be greater than that of normal
brain tissue (Bloch et al., 1961). None of our patients tolerated an incident
dose of 200 r daily, to each cerebral hemisphere, for longer than 3 consecutive
days. This applied not only to patients who were already drowsy, but also to
patients who were fully alert and ambulant before irradiation and who may have
already received several courses of irradiation under hypothermia at a lower
daily dose rate.
Further evidence for an increased tissue response to irradiation under hypo-
thermia wasobtainedbyBloom andDawson (1961) who demonstrated anincreased
mortality in mice exposed to whole-body irradiation at 31-33° C.
The nature of the increased response of tissues to irradiation under mild
hypothermia is unknown. Increased tissue oxygen tension resulting from a
lowered metabolic rate, or humoral factors arising from tissue breakdown or
endocrine changes are possible explanations. These have been considered else-
where (Bloom and Dawson, 1961).
At the present time these observations concerning the treatment of intra-
cranial gliomas are largely academic. There is no evidence that life is prolonged
as a result of irradiation to the brain under conditions of mild hypothermia.
The immediate reponse to irradiation is greater than would be expected at normal
body temperature, but subsequently, as at normal temperature, the tumour
grows again, leading to death.
The use of induced prolonged hypothermia alone does not necessarily carry
an excessive mortality. The mortality from hypothermia combined with cerebral
irradiation in cases of brain tumour in this study was 33%, although in terms of
80 episodes of hypothermia it was 12.5%. With the experience now gained it is
thought that this can be further reduced. Fay (1941, 1959) used prolonged
whole-body hypothermia without irradiation for the treatment of cases of non-
cerebral malignancy. He reported 19 deaths in 124 patients during 169 episodes
of hypothermia (1-8 days at 27-32° C.), a mortality rate of 15 and 11%, respec-
tively. The high mortality reported in accidental hypothermia (50-80%) is
probably related to the factors precipitating this condition, such as drug intoxica-
tion and cerebral injury.
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SUMMARY AND CONCLUSIONS
(1) Thirty patients suffering from cerebral glioblastoma multiforme (astro-
cytoma grades Il and IV) have been treated by surgery, followed by irradiation
to the brain under conditions of mild whole-body hypothermia (30-33° C.).
(2) Under these conditions there is an increase in the sensitivity of cerebral
tissues such that patients will tolerate an incident dose of 200 r daily, to each
cerebral hemisphere, for not longer than three consecutive days. There is some
evidence that the response of the tumour is greater than that of normal brain
tissue. However, life was not prolonged by this treatment.
(3) Ten patients died during treatment. The mortality for the total number
of episodes of hypothermia was 12X5%. The high case mortality was considered
to be due largely to the combined effects of hypothermia plus irradiation and
not from the hypothermia alone.
(4) It is suggested that an increase in radio-sensitivity may also be a property
ofother tissues ofthe body during mild whole-body cooling.
(5) Changes in haematocrit and haemoglobin values, in red and white cell
count and in platelet count during prolonged hypothermia have been described.
(6) Increase in cerebrospinal fluid protein was observed in a small number of
patients during cerebral irradiation under hypothermia, and during rewarming
following hypothermia, with or without irradiation.
(7) Five patients developed temporary partial deafness and one of these
complained also of impairment of sense of taste and smell following irradiation
to the brain under hypothermia.
(8) Acute pancreatitis occurred in 2 patients and acute epididymo-orchitis
in one patient during 80 episodes of prolonged hypothermia.
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